See All Slides - tctmd.com

Slides

Presentation TCT 2025

Bioresorbable Scaffolds as a Preferred Treatment for Ruptured Plaques and Younger ACS Patients: Is It Still a Possibility?

Presenter: Maciej Lesiak

October 28, 2025

Presentation TCT 2025

TCT 851: TAVR Versus Surveillance in Patients with Moderate Aortic Stenosis and Heart Failure: A Crossover-Censored Analysis of the TAVR UNLOAD Trial

Presenter: Philipp von Stein

October 28, 2025

Presentation TCT 2025

My Tips and Tricks for Prevention and Management of Perforations Related to Calcium Management Tools

Presenter: Bilal Iqbal

October 28, 2025

Presentation TCT 2025

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient: Paladin, CGuard or “How I usually do it?”

Presenter: Peter A. Soukas

October 28, 2025

Presentation TCT 2025

Case 1

Presenter: James M. McCabe

October 28, 2025

Presentation TCT 2025

TCT 241: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

Presenter: Matthias Lutz

October 28, 2025

Presentation TCT 2025

S Flex Netherlands registry

Presenter: Rohit Oemrawsingh

October 28, 2025

Presentation TCT 2025

TCT 239: OCT-Based Plaque Burden Estimation, Vulnerable Plaque Prevalence, and Scaffold Performance in Patients Treated With a Bioresorbable Magnesium Scaffold: A Sub analysis of the BIOMAG-I Study

Presenter: Pablo M. Rubio

October 28, 2025

Presentation TCT 2025

TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

Mitigating Stroke Risk in TAVR: Role of SENTINEL Embolic Protection

Presenter: Alexandra J. Lansky

October 28, 2025

Advertisement

Slides

Bioresorbable Scaffolds as a Preferred Treatment for Ruptured Plaques and Younger ACS Patients: Is It Still a Possibility?

TCT 851: TAVR Versus Surveillance in Patients with Moderate Aortic Stenosis and Heart Failure: A Crossover-Censored Analysis of the TAVR UNLOAD Trial

My Tips and Tricks for Prevention and Management of Perforations Related to Calcium Management Tools

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient: Paladin, CGuard or “How I usually do it?”

Case 1

TCT 241: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

S Flex Netherlands registry

TCT 239: OCT-Based Plaque Burden Estimation, Vulnerable Plaque Prevalence, and Scaffold Performance in Patients Treated With a Bioresorbable Magnesium Scaffold: A Sub analysis of the BIOMAG-I Study

TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies

Mitigating Stroke Risk in TAVR: Role of SENTINEL Embolic Protection

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content